the aim of this study was to analyze the incidence of these causes by serial roentgenogram , clinical , microbiological and laboratory tests in 21 patients ( pts ) with relapsed acute leukemia ( 18 x myeloid , 3 x lymphoblastic ) , an aml-pt ( acute myeloid leukemia ) suffering from secondary leukemia , and three pts with primary refractory leukemia following treatment with intermediate ( im ) and high-dose cytosine arabinoside ( hd-ara c ) , in combination with amsacrine ( amsa ) ( n = 19 ) , etoposide ( vp 16 ) ( n = 5 ) or mitoxantrone ( n = 1 ) .
C0023467
acute myeloid leukemia
C0015133
etoposide